Media Centre

Access our press/media kit

Videos

GDPR at EORTC
Tailoring medicine to patient needs
EORTC: The future of cancer therapy #WeAreEORTC
2019 World Cancer Day

Previous 123 Next

Press Releases

24 Jun 2026

News,Policy,Press release

EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
17 May 2026

Breast Cancer Group,News,Press release,Radiation Oncology Group

Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
25 Nov 2025

Press release,Quality of Life Group

SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in cancer clinical trials
21 Oct 2025

Brain Tumour Group,Genito-Urinary Cancers Group,Head and Neck Cancer Group,News,Press release,Quality of Life Group,Soft Tissue and Bone Sarcoma Group

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

Previous 123 Next

Latest Newsletter

Subscribe to our newsletter

News

Filter on topic

9 Jun 2026

News,Quality of Life Group

New study confirms a key quality of life tool can be used with adolescents with cancer
8 Jun 2026

News

“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
20 May 2026

News

This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
1 May 2026

Lymphoma Group,News

Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
30 Apr 2026

News

EORTC’s presence at ESTRO 2026
28 Apr 2026

News

Independent, academic cancer trials are vital to improve patient outcomes worldwide
24 Apr 2026

Diagnostic and Therapeutic Imaging,News

EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
23 Apr 2026

News

Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value
17 Apr 2026

News,Soft Tissue and Bone Sarcoma Group

In Memoriam of Martine Van Glabbeke (1951-2026)
27 Feb 2026

News

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

Previous 123 Next

Cookie	Duration	Description
_GRECAPTCHA	5 months 27 days	This cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	1 year	This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.

Cookie	Duration	Description
IDE	1 year 24 days	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
YSC	session	This cookies is set by Youtube and is used to track the views of embedded videos.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
ep201	30 minutes	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.
ep202	3 months	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.

Media centre

Videos

GDPR at EORTC

Tailoring medicine to patient needs

EORTC: The future of cancer therapy #WeAreEORTC

2019 World Cancer Day

Press Releases

EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer

SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in cancer clinical trials

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

Latest Newsletter

Sign up for EORTC Newsletter

News

New study confirms a key quality of life tool can be used with adolescents with cancer

“Changing practice, improving lives”: EORTC publishes its Annual Report 2025

This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research

Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

EORTC’s presence at ESTRO 2026

Independent, academic cancer trials are vital to improve patient outcomes worldwide

EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group

Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value

In Memoriam of Martine Van Glabbeke (1951-2026)

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

Media centre

Videos

GDPR at EORTC

Tailoring medicine to patient needs

EORTC: The future of cancer therapy #WeAreEORTC

2019 World Cancer Day

Press Releases

EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials

Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer

SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in cancer clinical trials

New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

Latest Newsletter

EORTC Newsletter: July 2026 Edition

News

New study confirms a key quality of life tool can be used with adolescents with cancer

“Changing practice, improving lives”: EORTC publishes its Annual Report 2025

This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research

Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

EORTC’s presence at ESTRO 2026

Independent, academic cancer trials are vital to improve patient outcomes worldwide

EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group

Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value

In Memoriam of Martine Van Glabbeke (1951-2026)

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases